ナノザイムの世界市場 - 産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合（2020年～2030年）

世界のナノザイムの市場規模は、2024年には2億9,105万米ドルとなり、予測期間中のCAGRは8.88%で、2030年には4億8,098万米ドルに達すると予測されています。

ナノザイムの世界市場は、研究開発活動の活発化、多様な産業における用途の拡大、革新的な触媒ソリューションに対する需要の高まりによって急速な成長を遂げています。ナノザイム（酵素のような性質を持つナノ材料）は、天然酵素と比較して、高い安定性、調整可能な触媒活性、費用対効果、大量生産の容易さといった独自の利点を提供します。例えば、2023年10月現在、米国国立がん研究所は、ヘンシファイ（NBTXR3）やパゼニールを含む13のナノテクノロジーに基づくがん薬物療法が臨床試験で有望であると認めています。ナノザイム市場の成長は、世界のがん罹患率の増加と、先進的で低侵襲な治療オプションに対する需要の高まりが原動力となっており、ナノザイムが将来のがん治療において重要な役割を担っていることを浮き彫りにしています。ナノザイムは、ヘルスケア、環境モニタリング、食品安全、工業バイオテクノロジーなどの分野で幅広く応用されています。ヘルスケアでは、診断、バイオセンシング、標的ドラッグデリバリーやがん治療を含む治療用途での使用が増加しています。天然酵素を模倣するその能力は、より迅速で高感度な疾患検出を可能にし、臨床転帰を改善します。環境への応用としては、汚染物質の検出や分解があり、水や空気の浄化に役立っています。さらに、ナノザイムは汚染物質や病原体の迅速な検出を可能にすることで、食品の安全性を高めます。例えば、2024年2月、合肥研究所のWang Hui教授のチームは、グラフェン量子ドット（GQD）から作られた画期的な金属を含まないナノザイムを発表し、ナノザイム技術を大きく前進させました。

多機能やハイブリッドナノザイムの開発などの技術進歩により、潜在的な用途がさらに拡大しています。ナノザイムベースのソリューションを開発するための政府機関や民間企業による投資の増加が、世界の市場開拓を後押ししています。さらに、慢性疾患の有病率の上昇と高度診断に対する意識の高まりが、市場の需要に大きく寄与しています。

主な市場促進要因

先端診断・治療に対する需要の高まり

主な市場課題

毒性と安全性への懸念

主な市場動向

ヘルスケア用途の優位性

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のナノザイム市場の展望

• 市場規模・予測
  • 金額・数量別
• 市場シェア・予測
  • タイプ別（セリウム系、酸化鉄系、マンガン系、金系・白金系、炭素系、その他）
  • 用途別（医療・バイオメディカル、環境科学技術、化学産業、食品産業、農業など）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ
• 価格分析

第6章 欧州のナノザイム市場の展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第7章 アジア太平洋のナノザイム市場の展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第8章 北米のナノザイム市場の展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第9章 中東・アフリカのナノザイム市場の展望

• 市場規模・予測
• 市場シェア・予測
• 価格分析
• 中東・アフリカ：国別分析
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

第12章 世界のナノザイム市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Bionics Enviro Tech
• NanJing NANOEAST BioTech CO.LTD
• Nanozyme Inc.,
• Institute of Biophysics Chinese Academy of Sciences
• GenScript Biotechnology
• Bloomage Bio Cargill Incorporated

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Nanozymes Market was valued at USD 291.05 million in 2024 and is expected to reach USD 480.98 million by 2030 with a CAGR of 8.88% during the forecast period. The global nanozymes market is witnessing rapid growth driven by increasing research and development activities, expanding applications across diverse industries, and the rising demand for innovative catalytic solutions. Nanozymes-nanomaterials with enzyme-like properties-offer unique advantages such as high stability, tunable catalytic activity, cost-effectiveness, and ease of large-scale production compared to natural enzymes. For instance, as of October 2023, the National Cancer Institute recognized 13 nanotechnology-based cancer drug therapies, including Hensify (NBTXR3) and Pazenir, showing promise in clinical trials. The growing nanozymes market is driven by the increasing global cancer incidence and rising demand for advanced, minimally invasive treatment options, highlighting nanozymes' critical role in future cancer therapies. Nanozymes find extensive applications in healthcare, environmental monitoring, food safety, and industrial biotechnology. In healthcare, they are increasingly used in diagnostics, biosensing, and therapeutic applications including targeted drug delivery and cancer treatment. Their ability to mimic natural enzymes enables faster and more sensitive disease detection, improving clinical outcomes. Environmental applications include pollutant detection and degradation, aiding in water and air purification efforts. Additionally, nanozymes enhance food safety by enabling rapid detection of contaminants and pathogens. For instance, in February 2024, Professor Wang Hui's team at Hefei Institutes unveiled a breakthrough metal-free nanozyme made from graphene quantum dots (GQDs), advancing nanozyme technology significantly.

Technological advancements, such as the development of multifunctional and hybrid nanozymes, are further expanding their potential uses. Increasing investments from government bodies and private players to develop nanozyme-based solutions are boosting market growth globally. Moreover, the rising prevalence of chronic diseases and growing awareness about advanced diagnostics contribute significantly to market demand.

Key Market Drivers

Rising Demand for Advanced Diagnostics and Therapeutics

The rising demand for advanced diagnostics and therapeutics is a critical driver propelling the growth of the global nanozymes market. Nanozymes, nanomaterials with enzyme-mimicking catalytic properties, have revolutionized the landscape of biomedical science by offering enhanced sensitivity, specificity, and stability compared to natural enzymes. In diagnostics, there is an increasing need for rapid, accurate, and cost-effective detection methods for various diseases, including cancer, infectious diseases, and chronic conditions. Nanozymes serve as highly efficient biosensors that facilitate early disease detection through catalytic amplification of signals, leading to faster and more reliable diagnostic outcomes. Their robustness under diverse environmental conditions and resistance to degradation make them especially suitable for point-of-care testing, where conventional enzymes often fall short. As the global population ages, neurodegenerative and neuroinflammatory diseases are becoming more widespread. A July 2024 publication in Advanced Functional Materials highlighted the exceptional catalytic activity and stability of nanozymes, emphasizing their potential as effective treatments for neurological disorders. With the projected increase in diseases such as Alzheimer's and Parkinson's, the demand for innovative therapies is rising sharply. Nanozymes, with their unique properties, offer promising solutions by improving treatment efficacy and targeting disease mechanisms more precisely. This growing need positions nanozymes at the forefront of next-generation neurological therapeutics.

In therapeutics, nanozymes are gaining prominence for their ability to act as artificial enzymes in targeted drug delivery, reactive oxygen species (ROS) scavenging, and tumor therapy. They can be engineered to specifically target diseased cells, minimizing side effects and improving treatment efficacy. The versatility of nanozymes also allows for their use in immunotherapy and gene therapy, where they can modulate biological pathways for enhanced therapeutic results. With the global healthcare industry increasingly focusing on personalized and precision medicine, nanozyme-based technologies offer a promising platform to meet these demands. The ongoing surge in chronic diseases such as cancer, cardiovascular disorders, and diabetes worldwide is intensifying the need for advanced diagnostic tools and novel therapeutic approaches. The limitations of natural enzymes-including instability, high production costs, and limited shelf life-have further accelerated the adoption of nanozymes. Consequently, healthcare providers and researchers are investing heavily in nanozyme research to develop innovative diagnostic kits and therapeutic agents, thereby driving the market's robust expansion. Overall, the growing demand for cutting-edge diagnostics and therapeutics remains a pivotal factor shaping the future trajectory of the global nanozymes market.

Key Market Challenges

Toxicity and Safety Concerns

Toxicity and safety concerns represent significant challenges to the growth and widespread adoption of nanozymes in various industries, particularly in healthcare, food safety, and environmental applications. Nanozymes are composed of nanomaterials that exhibit enzyme-like catalytic properties; however, their nanoscale size and unique physicochemical characteristics raise questions about their biocompatibility and potential adverse effects. One of the primary concerns is cytotoxicity-nanozymes may interact unpredictably with cells and tissues, potentially causing oxidative stress, inflammation, or DNA damage. Such toxicological effects could limit their safe use in therapeutic applications, diagnostics, and drug delivery systems where direct contact with human cells is inevitable.

The long-term effects of nanozymes on the human body and the environment are not yet fully understood, which complicates risk assessment and regulatory approval. The persistence and bioaccumulation of nanozymes in biological systems or ecosystems could pose environmental hazards, particularly if released unintentionally during manufacturing or disposal. This uncertainty leads to cautious approaches by regulatory bodies and end-users, slowing market penetration. Addressing these safety concerns requires extensive toxicological studies, standardized testing protocols, and improved nanozyme design focused on minimizing harmful interactions while preserving catalytic efficiency. Researchers are exploring surface modifications, biodegradable materials, and safer synthesis methods to reduce toxicity risks. Furthermore, transparent communication of safety data and regulatory compliance will be critical in building trust among consumers, healthcare professionals, and regulatory agencies. While nanozymes hold immense potential, overcoming toxicity and safety challenges remains essential to ensure their responsible and sustainable adoption in the global market.

Key Market Trends

Dominance of Healthcare Applications

The dominance of healthcare applications is a major driving force behind the rapid growth of the global nanozymes market. Nanozymes-nanomaterials that mimic natural enzymes-have revolutionized healthcare by offering enhanced stability, catalytic efficiency, and versatility compared to traditional enzymes. Their unique properties have made them indispensable in diverse healthcare areas, including diagnostics, therapeutics, biosensing, and drug delivery, solidifying their critical role in modern medicine. One of the primary healthcare applications of nanozymes lies in disease diagnostics. Nanozyme-based biosensors enable highly sensitive and rapid detection of biomarkers for various diseases such as cancer, infectious diseases, cardiovascular disorders, and neurological conditions. Unlike natural enzymes, nanozymes exhibit superior stability under harsh physiological conditions, ensuring reliable performance in point-of-care testing devices and clinical laboratories. This capability supports early diagnosis, which is essential for improving patient outcomes and reducing healthcare costs.

In therapeutics, nanozymes offer promising alternatives to conventional enzyme therapies. They can catalyze specific biochemical reactions within the body, assist in targeted drug delivery, and scavenge harmful reactive oxygen species (ROS), which are implicated in numerous diseases. Their ability to be engineered for specificity allows for precise treatment with minimized side effects, enhancing the safety and efficacy of therapies. Nanozymes are being integrated into advanced biosensing platforms for real-time monitoring of disease progression and treatment response. This facilitates personalized medicine approaches, where therapies can be tailored to individual patient needs. The healthcare sector's growing demand for innovative, cost-effective, and reliable enzyme alternatives continues to propel nanozyme research and commercialization. Investments by pharmaceutical companies, research institutions, and healthcare providers further reinforce this trend. As a result, healthcare applications currently account for the largest market share in the nanozymes industry and are expected to maintain this dominance well into the future, driving continued innovation and market expansion.

Key Market Players

• Bionics Enviro Tech
• NanJing NANOEAST BioTech CO.LTD
• Nanozyme Inc.,
• Institute of Biophysics Chinese Academy of Sciences
• GenScript Biotechnology
• Bloomage Bio Cargill Incorporated

Report Scope:

In this report, the Global Nanozymes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanozymes Market, By Type:

• Cerium based
• Iron oxide-based
• Manganese-Based
• Gold-Based
• Platinum-Based
• Others

Nanozymes Market, By Application:

• Medical and Bio-Medical Application
• Environmental Science and Technology
• Chemical Industry
• Food Industry
• Agriculture
• Others

Nanozymes Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nanozymes Market.

Available Customizations:

Global Nanozymes Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customers

5. Global Nanozymes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Cerium based, Iron oxide-based, Manganese-Based, Gold-Based and Platinum-Based, Carbon-Based, and Others)
  • 5.2.2. By Application (Medical and Bio-Medical Applications, Environmental science and technology, Chemical Industry, Food Industry, Agriculture and Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map
• 5.4. Pricing Analysis

6. Europe Nanozymes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Cerium based, Iron oxide-based, Manganese-Based, Gold-Based and Platinum-Based, Carbon-Based, and Others)
  • 6.2.2. By Application (Medical and Bio-Medical Applications, Environmental science and technology, Chemical Industry, Food Industry, Agriculture and Others)
  • 6.2.3. By Region
• 6.3. Pricing Analysis
• 6.4. Europe: Country Analysis
  • 6.4.1. France Nanozymes Market Outlook
    • 6.4.1.1. Market Size & Forecast
      • 6.4.1.1.1. By Value & Volume
    • 6.4.1.2. Market Share & Forecast
      • 6.4.1.2.1. By Type
      • 6.4.1.2.2. By Application
  • 6.4.2. Germany Nanozymes Market Outlook
    • 6.4.2.1. Market Size & Forecast
      • 6.4.2.1.1. By Value & Volume
    • 6.4.2.2. Market Share & Forecast
      • 6.4.2.2.1. By Type
      • 6.4.2.2.2. By Application
  • 6.4.3. United Kingdom Nanozymes Market Outlook
    • 6.4.3.1. Market Size & Forecast
      • 6.4.3.1.1. By Value & Volume
    • 6.4.3.2. Market Share & Forecast
      • 6.4.3.2.1. By Type
      • 6.4.3.2.2. By Application
  • 6.4.4. Italy Nanozymes Market Outlook
    • 6.4.4.1. Market Size & Forecast
      • 6.4.4.1.1. By Value & Volume
    • 6.4.4.2. Market Share & Forecast
      • 6.4.4.2.1. By Type
      • 6.4.4.2.2. By Application
  • 6.4.5. Spain Nanozymes Market Outlook
    • 6.4.5.1. Market Size & Forecast
      • 6.4.5.1.1. By Value & Volume
    • 6.4.5.2. Market Share & Forecast
      • 6.4.5.2.1. By Type
      • 6.4.5.2.2. By Application

7. Asia-Pacific Nanozymes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Cerium based, Iron oxide-based, Manganese-Based, Gold-Based and Platinum-Based, Carbon-Based, and Others)
  • 7.2.2. By Application (Medical and Bio-Medical Applications, Environmental science and technology, Chemical Industry, Food Industry, Agriculture and Others)
  • 7.2.3. By Region
• 7.3. Pricing Analysis
• 7.4. Asia-Pacific: Country Analysis
  • 7.4.1. China Nanozymes Market Outlook
    • 7.4.1.1. Market Size & Forecast
      • 7.4.1.1.1. By Value & Volume
    • 7.4.1.2. Market Share & Forecast
      • 7.4.1.2.1. By Type
      • 7.4.1.2.2. By Application
  • 7.4.2. India Nanozymes Market Outlook
    • 7.4.2.1. Market Size & Forecast
      • 7.4.2.1.1. By Value & Volume
    • 7.4.2.2. Market Share & Forecast
      • 7.4.2.2.1. By Type
      • 7.4.2.2.2. By Application
  • 7.4.3. Japan Nanozymes Market Outlook
    • 7.4.3.1. Market Size & Forecast
      • 7.4.3.1.1. By Value & Volume
    • 7.4.3.2. Market Share & Forecast
      • 7.4.3.2.1. By Type
      • 7.4.3.2.2. By Application
  • 7.4.4. South Korea Nanozymes Market Outlook
    • 7.4.4.1. Market Size & Forecast
      • 7.4.4.1.1. By Value & Volume
    • 7.4.4.2. Market Share & Forecast
      • 7.4.4.2.1. By Type
      • 7.4.4.2.2. By Application
  • 7.4.5. Australia Nanozymes Market Outlook
    • 7.4.5.1. Market Size & Forecast
      • 7.4.5.1.1. By Value & Volume
    • 7.4.5.2. Market Share & Forecast
      • 7.4.5.2.1. By Type
      • 7.4.5.2.2. By Application

8. North America Nanozymes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Cerium based, Iron oxide-based, Manganese-Based, Gold-Based and Platinum-Based, Carbon-Based, and Others)
  • 8.2.2. By Application (Medical and Bio-Medical Applications, Environmental science and technology, Chemical Industry, Food Industry, Agriculture and Others)
  • 8.2.3. By Region
• 8.3. Pricing Analysis
• 8.4. North America: Country Analysis
  • 8.4.1. United States Nanozymes Market Outlook
    • 8.4.1.1. Market Size & Forecast
      • 8.4.1.1.1. By Value & Volume
    • 8.4.1.2. Market Share & Forecast
      • 8.4.1.2.1. By Type
      • 8.4.1.2.2. By Application
  • 8.4.2. Canada Nanozymes Market Outlook
    • 8.4.2.1. Market Size & Forecast
      • 8.4.2.1.1. By Value & Volume
    • 8.4.2.2. Market Share & Forecast
      • 8.4.2.2.1. By Type
      • 8.4.2.2.2. By Application
  • 8.4.3. Mexico Nanozymes Market Outlook
    • 8.4.3.1. Market Size & Forecast
      • 8.4.3.1.1. By Value & Volume
    • 8.4.3.2. Market Share & Forecast
      • 8.4.3.2.1. By Type
      • 8.4.3.2.2. By Application

9. Middle East and Africa Nanozymes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Cerium based, Iron oxide-based, Manganese-Based, Gold-Based and Platinum-Based, Carbon-Based, and Others)
  • 9.2.2. By Application (Medical and Bio-Medical Applications, Environmental science and technology, Chemical Industry, Food Industry, Agriculture and Others)
  • 9.2.3. By Region
• 9.3. Pricing Analysis
• 9.4. MEA: Country Analysis
  • 9.4.1. Saudi Arabia Nanozymes Market Outlook
    • 9.4.1.1. Market Size & Forecast
      • 9.4.1.1.1. By Value & Volume
    • 9.4.1.2. Market Share & Forecast
      • 9.4.1.2.1. By Type
      • 9.4.1.2.2. By Application
  • 9.4.2. UAE Nanozymes Market Outlook
    • 9.4.2.1. Market Size & Forecast
      • 9.4.2.1.1. By Value & Volume
    • 9.4.2.2. Market Share & Forecast
      • 9.4.2.2.1. By Type
      • 9.4.2.2.2. By Application
  • 9.4.3. South Africa Nanozymes Market Outlook
    • 9.4.3.1. Market Size & Forecast
      • 9.4.3.1.1. By Value & Volume
    • 9.4.3.2. Market Share & Forecast
      • 9.4.3.2.1. By Type
      • 9.4.3.2.2. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

12. Global Nanozymes Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Bionics Enviro Tech
• 14.2. NanJing NANOEAST BioTech CO.LTD
• 14.3. Nanozyme Inc.,
• 14.4. Institute of Biophysics Chinese Academy of Sciences
• 14.5. GenScript Biotechnology
• 14.6. Bloomage Bio Cargill Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer